Michael McCleod

发表

Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.

Nicholas Iannotti, Taral Patel, Thomas J. Lynch, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study

Sameera R. Wijayawardana, Ravi Salgia, R. Salgia, 2017, Investigational New Drugs.